Arcturus Therapeutics Holdings (ARCT) EBIT Margin Growth (3y) (2021 - 2026)
Arcturus Therapeutics Holdings (ARCT) EBIT Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -40,178.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 530.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arcturus Therapeutics Holdings | 217.14 Mn | 5.76 Mn | - | -142,211.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -142,211.00 |
| Dec 31, 2025 | -51,083.00 |
| Sep 30, 2025 | 17,904.00 |
| Jun 30, 2025 | 4,049.00 |
| Mar 31, 2025 | 90,343.00 |
| Dec 31, 2024 | 50,304.00 |
| Sep 30, 2024 | 218,273.00 |
| Jun 30, 2024 | 264,229.00 |
| Mar 31, 2024 | 263,114.00 |
| Dec 31, 2023 | 132,961.00 |
| Sep 30, 2023 | 85,468.00 |
| Jun 30, 2023 | -9,395.00 |
| Mar 31, 2023 | 37,597.00 |
| Dec 31, 2022 | 44,022.00 |
| Sep 30, 2022 | -4,578.00 |
| Jun 30, 2022 | -7,590.00 |
| Mar 31, 2022 | -81,109.00 |
| Dec 31, 2021 | -64,034.00 |
| Sep 30, 2021 | -208,124.00 |
| Jun 30, 2021 | -226,253.00 |